Novel Multi-Strain E3 Probiotic Formulation Improved Mental Health Symptoms and Sleep Quality in Hong Kong Chinese.

Mental health issues have emerged as a significant concern in public health, given their association with physical and psychological comorbidities and the resultant socioeconomic burdens. Recent studies have highlighted the interplay between gut microbes and brain functions through the gut-brain axis. To investigate this further, we conducted a targeted 16S rRNA sequencing and comprehensive bioinformatic analysis among Southern Chinese individuals to explore the role of the gut microbiome in depression, anxiety, and sleep disturbance. We analyzed the differences in the gut microbiome profile of 68 participants with sleep disturbance and mood symptoms before and after an 8-week course of a novel oral E3 multi-strain probiotics formula. The results revealed a significant improvement in subjective sleep quality (PSQI: mean 8.79 at baseline vs. 7.10 at week 8, < 0.001), depressive symptoms (PHQ9: mean 6.17 at baseline vs. 4.76 at week 8, < 0.001), and anxious symptoms (GAD7: mean 4.90 at baseline vs. 3.76 at week 8, < 0.001). Additionally, there were notable differences in beta diversity (weighted UniFrac; = 0.045) and increased Firmicutes/Bacteroidetes (F/B) ratio ( = 4 × 10) were observed in the gut microbiome analysis. Furthermore, the relative abundance of ( < 0.001), ( < 0.001), ( < 0.001) and ( < 0.001) were significantly increased after the 8-week probiotic supplementation. Our study suggests that the gut microbial landscape varies between responders and non-responders at multiple levels, including genera, species, functional, and network interaction. Notably, the use of probiotics in populations with depressive or anxious symptoms and poor sleeping quality remodeled the gut microbiome and demonstrated improved mood and sleep quality.